Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients

por Subbiah, Vivek, Bupathi, Manojkumar, Kato, Shumei, Livingston, Andrew, Slopis, John, Anderson, Pete M., Hong, David S.
Publicado 2015

Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumo...

por Subbiah, Vivek, Brown, Robert E., Jiang, Yunyun, Buryanek, Jamie, Hayes-Jordan, Andrea, Kurzrock, Razelle, Anderson, Pete M.
Publicado 2013

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST

por Kairemo, Kalevi, Rohren, Eric M, Anderson, Pete M, Ravizzini, Gregory, Rao, Arvind, Macapinlac, Homer A, Subbiah, Vivek
Publicado 2019

223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy

por Anderson, Pete M, Scott, Jacob, Parsai, Shireen, Zahler, Stacey, Worley, Sarah, Shrikanthan, Sankaran, Subbiah, Vivek, Murphy, Erin
Publicado 2020

Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

por Egas-Bejar, Daniela, Anderson, Pete M., Agarwal, Rishi, Corrales-Medina, Fernando, Devarajan, Eswaran, Huh, Winston W., Brown, Robert E, Subbiah, Vivek
Publicado 2014